Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Yoko Momonoi, M.S.

Executive Director, Global Regulatory CMC Cell and Gene Therapy
Takeda Pharmaceuticals

Yoko Momonoi has 15+ years of experience in the pharma/biotech industry. Currently, Yoko leads the Cell & Gene Therapy group in Global Regulatory CMC at Takeda. She oversees the regulatory strategy of various genetically modified and non-modified allogeneic cell therapies such as MSCs, NK cells, T cells and iPSCs. Prior to joining Takeda, Yoko has held positions of increasing responsibility in process engineering, process development and regulatory CMC at Celgene, Novartis, and Genentech.

Disclosure information not submitted.

Presentation(s):